New modified brassinosteroids (BS) with a full set of specific functional groups and with an additional one at C-26 have been synthesized and used as haptens for enzyme-linked immunosorbent assay. The haptens were conjugated to bovine serum albumin (BSA) and the obtained immunoconjugates were applied for production of polyclonal antibodies. A conjugation of the haptens to horseradish peroxidase (HRP) gave the corresponding enzyme-labeled BS -another principal component for immuno-competitive analysis. The steroids were linked to proteins through spacers at the terminal side chain carbon atom (C-26) that made both the cyclic part and the side chain exposed for recognition by antibodies. It allowed maximization of their sensitivity and for the first time made possible immunochemical distinguishing of the most important group of natural BS, B-lactones, from B-ketones and 6-deoxo derivatives. The synthesis of haptens based on a sequence of transformations starting from stigmasterol included Claisen rearrangement of 22-allylic ethers as a key reaction in the side chain construction.
Brassinosteroids are well known nowadays as a class of plant hormones, which are critically important for growth, development and adaptation of plants to the environment [1] [2] [3] . They initiate a variety of signaling events in the plant cell and via a cross-talk with other phytohormones influence major physiological processes that determine total plant productivity and quality parameters of crops. That is why, along with basic research in this area, many efforts have been directed to the agricultural use of BS. To date, they are realized in newly developed agrochemicals, which include natural BS, such as 24-epibrassinolide and 28-homobrassinolide, as active ingredients, and which are widely applied for crop production in different countries [4] [5] [6] . A characteristic feature of naturally occurring and agriculturally applied BS is their ability to produce physiological effect at extremely low doses. This becomes apparent from the very low natural content of BS in plant tissues as well as from their low expenditure rates in agricultural use. The latter vary in a range of 5-50 mg/ha. In plants, the highest measured concentration is about 10 -5 %, but usually it is much lower being close to (or less than) the detection limits of existing analytical methods. Such a concentration creates many difficulties for quantification of BS that is absolutely necessary in studies of their natural distribution, biosynthesis, metabolism, cell localization, developmental dynamics and other characteristic features important for understanding the mechanism of their action and for efficient agricultural use. Rapid, specific and highly sensitive analytical methods are also required for various aspects of BS practical application (for example, analysis in agrochemicals, in food, and in soil).
The traditional approach, including multistep purification in combination with specific bio-tests, which was used mostly in the early period of BS studies, is a complex and time consuming procedure. To simplify the process and to avoid isolation of BS in a pure state, a chromatographic approach (GC or HPLC) in combination with mass-spectrometry is usually used. In this case, the determination of BS should be achieved by comparing these (usually in a chemically modified form) with specially synthesized authentic standards. Many versions of GC-MS [7] [8] [9] [10] and HPLC-MS [11] [12] [13] [14] [15] [16] [17] analysis have been developed and widely applied to different plant species that have allowed the discovery of a number of naturally occurring BS [18] , three of which were published recently by our research group [19] [20] [21] . Unfortunately, all these approaches need rather sophisticated equipment and at the same time are rather laborious and expensive. These are the reasons why they are not suitable for online monitoring and large-scale routine analysis of BS in plant samples.
A good alternative to determine steroids in natural sources is immunochemical analysis requiring much simpler sample preparation procedures. Several attempts have been made on the development of immunochemical assays for BS analysis [22] [23] [24] , which were mostly based on radio-immune methodology using radio-labeled BS as markers in an immuno-competitive assay. Until recently there were no published results on the development of an immunoenzymatic approach to BS-analysis, where an enzyme (usually HRP) is used for the labeling of BS. At the same time, the latter one looks especially practical because of the ease of the procedure and the relatively simple equipment required for it. Another attractive feature of the immunoenzymatic method is the absence of radioactive components in the assay system, which is a kind of guarantee for its ecological safety. These are the reasons why this type of assay can be considered as the most promising for largescale monitoring of BS both in research and in agricultural applications.
The first data on the elaboration of an immunoenzymatic assay for BS were reported recently [25] [26] [27] , and since then more results in this direction have been published [28, 29] . All these showed reasonable sensitivity in respect to measuring antigens that was comparable with the best chromatographic methods. At the same time, they had serious limitations in the structural differentiation between major groups of natural BS (lactones, ketones and 6-deoxo-BS), as well as all previously described immunoassays. Broad substrate specificity due to the detection of related molecules differing in the structure of sites adjacent to the immunogenic moiety is typical for these assays. Being themselves non-immunogenic substances, BS should be chemically attached to an immunogenic molecule, and only then the conjugate can be used for immunization of animals. Selectivity and sensitivity of interaction of the produced antibodies with a measuring antigen greatly depend on the way and place of steroid attachment to the immunogenic moiety, the role of which is usually played by a transport protein, such as BSA. In the case of BS, the easiest place for attachment of the protein to steroids (haptens) is their 6-keto function, which via a modification and construction of a spatial linker allows binding of the protein moiety to the BS-molecule at the C-6 position. For example, compound 1 (Figure 1 ) was reported for conjugation with BSA in recently published assays [25] [26] [27] [28] [29] .
Unfortunately, this approach, although suitable for making the conjugates in human steroid series, is clearly not the best one for application to BS, where the structure and functionality of the cycle B play a principal role in their physiological properties. Thus, 6-oxo-7-oxa-, 6-oxo-and 6-deoxo-derivatives create three important groups of natural BS differing in their activity and role in plants, and all these cannot be distinguished efficiently by antibodies raised toward the BS-BSA conjugate having a linker at C-6.
The purpose of the present research was to synthesize newly modified BS with a full set of specific functional groups and with an additional one in the terminal part of the side chain (at C-26) and to use them as haptens for conjugating to BSA 2 and HRP 3 ( Figure 2 ) for further production of antibodies and for studying their properties. We were interested to see if the antibodies might differentiate between the lactone and other structural types of the cycle B. If this is the case, it would be possible to raise specific antibodies to all major cyclic structures for their selective determination. Binding the proteins through spacers at C-26 should allow both the cyclic part and the side chain to be exposed for recognition by the antibodies to maximize their specificity in respect to the cycle B.
Here we report the synthesis of two haptens via a sequence of transformations starting from stigmasterol and including Claisen rearrangement of 22-allylic ethers as a key reaction for the side chain construction. Another task was the preliminary investigation of the properties of polyclonal antibodies resulting from immunization of rabbits with the synthesized C-26 immunoconjugate.
Ester 5 was prepared in 5 steps from the commercially available stigmasterol (4) according to a known procedure [30] . Hydride reduction of 5 followed by acetylation of intermediate 26-alcohol gave the acetate 6 ( Figure 3 ). For further synthetic purposes, a Δ 2 -double bond had to be introduced to ensure the formation of a 2α,3α-diol function. An optimal synthetic protocol to achieve this was the initial regeneration of a 3β-hydroxy-Δ 5 -system by acidic treatment of 6, followed by transformation of 7 into 8 through the reaction sequence involving i-steroidal rearrangement. A one-step conversion to Δ 2 -6-ketone (9) was performed by heating 3α,5-cyclo-6-ketone (8) in DMF in the presence of pyridinium hydrobromide. Compound 9 was readily and quantitatively saponified to 10.
The next task was stereoselective dihydroxylation of 10 to form the 2α,3α,22R,23R-tetrahydroxy functionality, characteristic of brassinosteroids. It is known that oxidation of steroidal Δ 22 -olefins with OsO 4 proceeds with formation of unnatural 22S,23S-isomers as main products [31] . The required natural 22R,23R-isomers are available via an asymmetric variant of this reaction (oxidation in the presence of quinidine catalysts; Sharpless dihydroxylation) [32] . Therefore, one would expect that Sharpless dihydroxylation should provide the necessary 22R,23R-isomer (11) . Nevertheless, experimental verification of this prediction seemed desirable, because no systematic study of Sharpless dihydroxylation has been reported until now for cholestane Δ 22 -olefins. In addition, all studied compounds substituted at C-26 were diastereomeric mixtures at C-25. As a result, little meaningful spectroscopic data could be obtained for 11 to provide its structure elucidation based on literature correlations.
A solution to the problem was found in the transformation of 11 into the known 28norcastasterone (16) . To remove the hydroxyl group at C-26, four other hydroxyl groups in 11 had to be protected. This was achieved by treatment of 11 with 2,2-dimethoxypropane in the presence of TsOH ( Figure 4 ). The reaction proceeded with formation of one product containing four methyl signals of isopropylidene groups at δ 1.34, 1.38, 1.38 and 1.51 in its 1 H NMR spectrum. This evidenced the presence of two acetonide groups in the newly formed product. However, its 1 H NMR spectrum was too complex to allow for differentiation between 1,2-acetonide (12a) and 1,4-acetonide (12b).
It is known that 1,2-acetonides are more stable than 1,3-acetonides, which in turn are more stable than 1,4-acetonides [33] . Thus we might expect the formation of the 1,2-acetonide (12a). To prove it strictly, the latter was subjected to Swern oxidation to give compound 13 showing a signal for an aldehyde proton at δ 9.68 in its 1 H NMR spectrum. This was possible only by oxidation of the 1,2-acetonide (12a) containing a primary hydroxyl group at C-26.
Reductive removal of the hydroxy group in 12a was effected via the tosylate 14, which was then subjected to nucleophilic substitution with KI and radical dehalogenation with Bu 3 SnH ( Figure 5 ). Complete deprotection of both isopropylidene groups of 15 led to a compound, the NMR spectral properties of which were identical to those exhibited by an authentic sample of 28-norcastasterone. This result could be considered as firm experimental evidence for the formation of the 22R,23R-isomer in Sharpless dihydroxylation of 10.
Initial model experiments for the preparation of hemisuccinates were performed with compound 12a ( Figure 6 ). Its reaction with succinic anhydride in pyridine in the presence of 4-dimethylaminopyridine (DMAP) led to hemisuccinate 17. Removal of isopropylidene protection by acidic hydrolysis gave cleanly the derivative containing a succinic moiety.
However, there was a possibility that under acidic conditions the succinic group could migrate to either the proximal C-23 or C-22 hydroxy groups. Because NMR spectra of 18 gave no clear answer to this question, it was decided to solve the problem in a way based on chemical transformation. Treatment of 18 with acetone in the presence of TsOH afforded a compound that was identical to the diacetonide 17, according to the NMR spectra. In this way, one can assert that no acyl migration took place under the conditions used for isopropylidene deprotection of 17.
For the preparation of hapten with a cyclic part characteristic for the most active brassinosteroids, compound 11 should be transformed into the corresponding lactone. Baeyer-Villiger oxidation could be achieved with 11 itself. However, this reaction proceeds with formation of a minor regioisomeric lactone, which can be more efficiently separated when all the hydroxy groups are protected as acetates. Therefore, 11 was first protected as a pentaacetate, which was then subjected to Baeyer-Villiger oxidation (Figure 7 ). Saponification of 19, followed by relactonization, led to the lactone 20.
The hemisuccinate group was linked in the same sequence of reactions as described above to afford ester 23 via intermediate diacetonides 21 and 22. The succinic moiety served as a spacer for attachment of bovine serum albumin and horse radish peroxidase. Rabbits were injected subcutaneously with the immunogenic conjugate 2 dissolved in phosphatebuffered saline and emulsified in Complete Freund's Adjuvant for the production of antisera. Immunization was carried out once per month during 6 months with periodical testing of the animal blood for binding ability for 28-norbrassinolide (25) .
The titers were determined as a working dilution of the antiserum that allows binding of the labeled antigen in the amount sufficient for plotting a calibration curve within the range 2.5 OD 450 -0.2 OD 450 [from maximal optical density of the sample having no measurable antigen to minimal optical density of the sample containing 28-norbrassinolide (25) at a concentration of 100 nmol/L]. Scatchard analysis of the results of three independent experiments on the binding of 28-norbrassinolide (25) in the samples with increasing concentrations of the phytohormones and permanent content of the labeled conjugate was used for measuring the Ka values. As a result of testing, the antiserum with the best binding characteristic (K a 8.9 х 10 9 M -1 ) was used for further work. The optimum conditions for the determination of 28-norbrassinolide 25 were found to be a 1,200,000-fold dilution of the antiserum. Standard 96-well plates, preliminary coated with anti-rabbit sheep antibodies, were used for indirect immobilization of the chosen rabbit antibodies that served as a basis of ELISA for determination of the phytohormones in concentrations higher than 0.3 nmol/L or 7 pg in 50 µL sample. Immunochemical analysis was performed according to a previously described method [29] . The interval of the BS concentrations from 0.3 to 100 nM was used for plotting the calibration curve ( Figure 8 ).
The results are expressed as B/B0 (%), where B/B0 is the ratio of the absorbance at 450 nm of ELISA in the presence of various concentrations of a competitive antigen to that in the absence of the competitive antigen.
The specificity of the antibodies was estimated from their ability for competitive binding to steroids differing structurally from 28-norbrassinolide (25) . Cross-reactions of different steroids, including a number of natural BS and related compounds, were studied ( Figure 9 ). Experiments showed that the obtained antibodies were highly specific for the determination of brassinosteroids of the lactone series. Among plant sterols, only a slight crossreactivity was noted for stigmasterol 4 (0.1%).
No cross-reactivity was found for other sterols (campesterol 39, cholesterol 40), or for other studied compounds with a similar cyclic part, such as pregnenolone (41) and androstenolone (42). Ecdysterone (43), a polyhydroxysteroid, but having another set of hydroxyl groups, also showed no crossreactivity. Very small cross-reactivity (if at all) was exhibited by 6-deoxo BS 35-38. The antibodies cross-reacted weakly with 6-ketones, with potencies ranging from 1.9% for 28-homocastasterone (32) to 10% for succinic ester 10. A strong cross-reactivity was observed for all studied lactones (up to 180%).
In conclusion, a new ELISA for the determination of BS has been developed. The assay is highly specific towards compounds containing a lactone moiety in Figure 9 : Cross reactivities of the antibodies with various steroids [in parenthesis: percentage of binding in relation to 28-norbrassinolide (25) ]. the B-ring (B-homo-7-oxa-6-oxo functionality) and is very sensitive. In addition, the present investigation made it possible to state that the proposed approach for haptens preparation based on binding the proteins through spacers at C-26 can be successfully applied for BS with other structural types of the cycle B.
Experimental
Melting points were taken on a Boetius micromelting point apparatus and are uncorrected. IR spectra were recorded on a UR-20 spectrophotometer in KBr tablets. 1 H and 13 C NMR spectra were obtained using a Bruker AVANCE 500 (Bruker Biospin) spectrometer operating at 500 MHz for 1 H and 125 MHz for 13 C. Chemical shifts were determined relative to the residual solvent peaks (CHCl 3 , δ = 7.26 for hydrogen atoms, δ = 77 for carbon atoms). The exact mass measurements were carried out on a Micromass MasSpec mass spectrometer operating in the 70 eV-EI mode. A direct insertion probe was used to introduce samples for accurate mass measurement by peak matching. All chemicals were of analytical grade. Natural brassinosteroids and their analogs were prepared in our laboratory [34] [35] [36] [37] . Reactions were monitored by TLC using aluminum or plastic sheets precoated with silica gel 60 F 254 (Merck Art. 5715). Column chromatography was carried out on silica gel 60 (Merck Art. 7734). -6β-methoxy-3α,5-cyclo-5α-cholest-22 en (6) : To a stirred solution of 6β-methoxy-3α,5cyclo-5α-cholest-22-en-26-oic acid ethyl ester 5 (4.71 g, 10.3 mmol, prepared according to [30] ) in diethyl ether, LiAlH 4 (1.0 g, 26 mmol) was added, dropwise. After stirring for 30 min at room temperature, an excess of LiAlH 4 was destroyed by addition of 15% NaOH solution. The precipitate was filtered off, and the filtrate evaporated. The residue was dissolved in pyridine (30 mL), and acetic anhydride (15 mL, 0.16 mol) was added. The mixture was kept at room temperature for 5 h, then diluted with water (100 mL) and extracted with EtOAc (3 x 40 mL). The combined extracts were dried over Na 2 SO 4 and evaporated. The residue was purified by column chromatography on SiO 2 (light petroleum - (7) : To a solution of acetate 6 (4.74 g, 10.3 mmol) in dioxane (90 mL), water (30 mL) and TsOH⋅H 2 O (0.5 g, 2.6 mmol) were added. The mixture was kept at 70 o C for 40 min, then cooled to room temperature and pyridine (0.5 mL) was added. Solvents were evaporated in vacuo, and the residue was chromatographed on SiO 2 (light petroleum -EtOAc 30: 
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26-Acetoxy-3α,5-cyclo-5α-cholest-22-en-6-one (8):
To a solution of alcohol 7 (4.40 g, 9.93 mmol) in pyridine (60 mL), TsCl (7.0 g, 36 mmol) was added. After the mixture was kept at room temperature for 15 h, it was diluted with water (400 mL) and extracted with CHCl 3 (3 x 80 mL). The combined extracts were dried over MgSO 4 and the solvent evaporated. The resulting oily product (6.39 g) was dissolved in acetone (410 mL), then water (31 mL, 1.7 mmol) and KOAc (1.56 g, 16 mmol) were added and the mixture was refluxed for 24 h. After cooling to 0 o C, Jones reagent (8 mL) was added to the stirred mixture during 20 min. Then isopropyl alcohol (25 mL) was added and stirring was continued for 20 min. The mixture was diluted with water (1300 mL) and extracted with CHCl 3 (3 x 100 (9) : A solution of 8 (1.86 g, 4.23 mmol) and pyridinium hydrobromide (2.11 g, 13.1 mmol) in DMF (42 mL) was refluxed for 2 h. After cooling, the solvent was evaporated in vacuo. The residue was chromatographed on SiO 2 (light petroleum -EtOAc 30:1 to 10:1 as eluent) to afford 1.1 g (59%) 9 as an oil. (19) . (10) : A mixture of acetate 9 (1.2 g, 2.7 mmol) and KOH (3.2 g, 57 mmol) in MeOH (64 mL) was stirred at room temperature for 45 min. Then AcOH (6.5 mL, 0.11 mmol) was added and stirring was continued for 10 min. Solvents were partly removed in vacuo, the mixture was diluted with water and extracted with 13 (22R,23R)-2α,3α,22,23,26-Pentahydroxy-5α cholestan-6-one (11) : To a stirred solution of dienone 10 (1.24 g, 3.1 mmol) in tert-butanol (60 mL), water (60 mL), MeSO 2 NH 2 (0.56 g, 3.83 mmol) and AD-mix β were added. The mixture was stirred at room temperature for 48 h. Then Na 2 SO 3 (3.0 g, 23 mmol) was added and stirring was continued for 1 h. Silica gel (70 mL) was added to the mixture and the solvents were evaporated in vacuo. The residue was loaded onto a column of silica gel. Elution with CHCl 3 and methanol (40:1 to 10:1) gave 1.31 g of oily product, which was crystallized from CHCl 3 -methanol to afford 726 mg (50%) 11 as white crystals. (22R,23R)-2α,3α,22,23-Bis(isopropylidenedioxy) (22R,23R)-2α,3α,22,23-Bis(isopropylidenedioxy)-5α-cholestan-6-on-26-al (13) : To a mixture of CH 2 Cl 2 (3 mL) and COCl 2 (0.2 mL), DMSO (0.4 mL) in CH 2 Cl 2 (0.8 mL) was added at -60ºC under argon. The mixture was stirred for 20 min, then alcohol 12a (25 mg, 46 μmol) in CH 2 Cl 2 (3 mL) was added, followed by dropwise addition of Et 3 N (1.5 mL). The mixture was allowed to warm to room temperature, then diluted with water and extracted with CHCl 3 . The extract was dried over MgSO 4 and the solvents evaporated. The residue was chromatographed on SiO 2 (cyclohexane -EtOAc 10:1 to 2:1 as eluent) to afford 15 mg (60%) 13 as an oil. 1 
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(22R,23R)-26-(p-Toluenesulfonyloxy)-2α,3α,22,23bis(isopropylidenedioxy)-5α-cholestan-6-one (14):
A mixture of alcohol 12a (38 mg, 70 μmol), pyridine (2 mL), TsCl (53 mg, 0.27 mmol) and DMAP (1 mg, 8 μmol) was kept at room temperature for 24 h. Then water (10 mL) was added and the mixture was extracted with CHCl 3 (3 x 10 mL). The combined extracts were dried over Na 2 SO 4 and evaporated. The residue was chromatographed on SiO 2 (cyclohexane -EtOAc 30:1 to 5:1 as eluent) to give 35 mg (73%) 14 as an oil. 1 (22R,23R)-2α,3α,22,23-Bis(isopropylidenedioxy) -5α-cholestan-6-one (15) : A mixture of tosylate 14 (55 mg, 78 μmol), KI (65 mg, 0.39 mmol) and acetone (2 mL) was refluxed for 48 h. The solvent was evaporated in vacuo, the residue diluted with water and extracted with EtOAc (3 x 10 mL). The combined extracts were dried over MgSO 4 and evaporated. Toluene (2 mL), Bu 3 SnH (0.2 mL, 0.75 mmol) and AIBN (2 mg, 12 μmol) were added to the residue. The mixture was stirred at 110ºC for 1 h, then the solvents were evaporated. The residue was chromatographed on SiO 2 (cyclohexane -EtOAc 30:1 to 10:1 as eluent) to give 22 mg (53%) 15 as an oil. 1 13 (22R,23R)-2α,3α,22,23-Tetrahydroxy-5α -cholestan-6-one (16) : A mixture of diacetonide 15 (22 mg, 41 μmol), AcOH (2.5 mL) and water (0.5 mL) was kept at 110ºC for 1 h, and then the solvents were evaporated. The residue was chromatographed on SiO 2 (CHCl 3 -MeOH 15:1 to 8:1 as eluent) to give 12 mg (64%) 16 as white crystals.
MP: 247-248ºC. Lit. [38] 254-255ºC, [35] 238-240ºC. 1 13 11.76, 11.94, 15.73, 20.21, 21.62, 22.92, 25.59, 26.15, 26.46, 26.86, 27.71, 27.91, 27.96, 28.01, 28.78, 29.38, 34.68, 35.89, 36.67, 38.21, 40.14, 41.60, 41.91, 45.93, 50.55, 52.22, 52.33, 55.48, 68.91, 71.22, 71.41, 74.21, 82.02, 107.03, 107.15, 171.23, 176.16, 210 .66.
Variant B:
A solution of tetraol 18 (20 mg, 35 μmol) and TsOH⋅H 2 O (5 mg, 26 μmol) in acetone was stirred at room temperature for 30 min. Saturated NaHCO 3 solution (0.1 mL) and silica gel (2 mL) were added and the solvents removed in vacuo. The residue was chromatographed on SiO 2 (cyclohexane -EtOAc 10:1 to 1:2 as eluent) to give 15 mg (65%) 17 as an oil. The 1 H and 13 C NMR spectra were identical to those obtained for this compound prepared according to Variant A.   (22R,23R)-2α,3α,22,23,26-Pentahydroxy-5α 22 -, C 23 -and C 26 -H). 13 C NMR (CDCl 3 +CD 3 OD): 11.11, 11.15, 12.68, 14.95, 17.61, 20.61, 23.19, 25.80, 26.92, 28.26, 28.45, 28.57, 35. (22R,23R)-2α,3α,22,23,26-Pentaacetoxy-В-homo-7 oxa-5α-cholestan-6-one (19) : A mixture of pentaol 11 (405 mg, 0.87 mmol), Ac 2 O (6 mL, 64 mmol), DMAP (39 mg, 0.32 mmol) and pyridine was kept at 65ºC for 24 h. Then it was diluted with water and extracted with EtOAc (3 x 40 mL). The combined extracts were dried over MgSO 4 and the solvents evaporated. The residue was purified by column chromatography on SiO 2 . The obtained oily product was dissolved in CH 2 Cl 2 (20 mL) and trifluoroperacetic acid [prepared from trifluoroacetic anhydride (3.0 mL) and 30% hydrogen peroxide (0.87 mL) in CH 2 Cl 2 (14 mL)] were added at -15ºC. The mixture was stirred for 5 h at -15ºC, then diluted with saturated Na 2 SO 3 and extracted with CH 2 Cl 2 (3 x 40 mL). The combined extracts were dried over MgSO 4 and the solvents evaporated. The residue was chromatographed on SiO 2 (light petroleum -EtOAc 20:1 to 5:1 as eluent) to give 400 mg (66%) 19 as an oil. 1 (22R,23R)-2α,3α,22,23,26-Pentahydroxy-В-homo-7 oxa-5α-cholestan-6-one (20) : To a solution of pentaacetate 19 (95 mg) in MeOH (4 mL), KOH (200 mg) was added. The mixture was refluxed for 1 h, then cooled to room temperature and AcOH (0.5 mL) was added. After 1.5 h, silica gel (3 mL) was added and the solvents evaporated in vacuo. The residue was loaded onto a column of SiO 2 . Elution with CHCl 3 -MeOH (15:1 to 6:1) gave 62 mg (93%) 20 as white crystals.
MP: 261-263ºC. 1 (22R,23R)-2α,3α,22,23-Bis(isopropylidenedioxy)-Вhomo-7-oxa-5α-cholestan-6-on-26-ol (21) : This was obtained from pentaol 20 as an oil, in 60% yield, according to the procedure described for the preparation of 12a. 1 (22R,23R)-2α,3α,22,23-Bis(isopropylidenedioxy)-Вhomo-7-oxa-5α-cholestan-6-on-26 (22R,23R)-2α,3α,22,23,26 
-Pentahydroxy-В-homo-7oxa-5α-cholestan-6-one 26-hemisuccinate (23):
This was obtained from the diacetonide 22 as white crystals, in 86% yield, according to the procedure, described for the preparation of 18.
MP: 225-227ºC. 1 
Synthesis of the immunogenic conjugate with BSA 2:
To a solution of DCC (13 mg, 63 μmol) in anhydrous dioxane (4 mL), a solution of hemisuccinate 23 (30 mg, 52 μmol) and N-hydroxysuccinimide (8 mg, 70 μmol) in anhydrous dioxane (6 mL) was added at 8-10°C. The reaction mixture was stirred for 30 min at this temperature and then for 6 h at room temperature. The precipitated dicyclohexylurea was removed by filtration, and the obtained solution of N-succinimide ester 24, without further processing, was added to a solution of BSA (60 mg in 10 mL of 0.1 M NaHCO 3 , pH 8.35).The mixture was kept for 20 h at room temperature, then an excess of activated ester and dioxane were removed by dialysis against 0.005 M NaCl to give, after lyophilization, 80 mg 2. The obtained conjugate 2 was frozen and stored at -18°C.
Synthesis of labeled antigen 3:
A solution of active N-succinimide ester 24 (3 mg, 4.4 µmol) was added to a solution of HRP (6 mg) in distilled water (600 µL) with 0.1 M NaHCO 3 (2-3 drops, pH 8.35). The reaction mixture was stirred at 10°C for 30 min, then at room temperature for 1.5 h, and purified on a column of Sephadex G25 (0.005 M NaCl as eluent). The yellow-brown fraction was collected, diluted with glycerol (1:2), and stored in a refrigerator at -18°C.
Immunization: A group of six rabbits was immunized with the conjugate 2. Every rabbit was injected into 10-15 points on its back subcutaneously with the conjugate (1 mg) dissolved in phosphate buffered saline (0.5 mL , pH 7.4) and emulsified in an equal volume of Complete Freund's Adjuvant. Intervals between the injections were 4 weeks. The injections were continued for 6 months, and blood from the auricular vein was taken regularly (7-10 days after the injections). The samples of blood serum were tested for their binding ability to conjugate 3; their titers (working dilutions), and the K a values were determined. Antibody immobilization: This was performed as described in our previous study [29] , except that the working dilution of a specific antibody solution ranged from 1:100,000 to 1:1,500,000.
Preparation of the calibrating samples:
The calibrating samples were prepared by the method for serial dilutions, as described earlier [29] . A 0.02 M phosphate buffer (pH 7.2) was used, which contained 0.1% BSA, 1% NaCl, and 0.02% Tween-20, with the addition of thimerosal as a preservative. The steroid concentrations in the calibration samples were 0, 0.3, 1, 3, 10, 30, and 100 nM.
Preparation of the solution of conjugate 3:
The working solution of labeled hapten for ELISA was prepared, as described earlier [29] , in the working buffer solution, with the addition of 0.01% thimerosal.
The ELISA procedure: This followed the protocol of our previous study [29] , except that the reaction was quenched by the addition of 50 µL of 5% H 2 SO 4 in each well.
Determination of cross-reactivity:
The specificity of the obtained antiserum was determined by competition experiments of various steroids with 28-norbrassinolide (25) for the binding to antibodies. The calibration samples of 28-norbrassinolide (25) and the solutions of other steroids were added to wells of the plate with the immobilized antibodies.
The analysis and results processing were performed as described above. The obtained results on conjugate 3 binding at different contents of the tested steroids in the sample were used for plotting the calibration curve. The concentrations of steroids inducing a 50% decrease in binding in comparison with a zero calibration curve were calculated. The effective cross-reaction value was calculated by the following equation:
CR (%) = K NB /K S x 100
where CR is the efficiency of cross-reaction, K NB and K S are concentrations of 28-norbrassinolide 25 and the tested steroid that induced the 50% decrease in the label binding, respectively.
